Vagus Nerve Stimulators Market is Expected to Witness Positive Growth With A CAGR of 9.06% by 2030, estimates DelveInsight

Vagus Nerve Stimulators companies are LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH, and others.
(Albany, USA) DelveInsight's Vagus Nerve Stimulators Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Vagus Nerve Stimulators companies in the market.

As per DelveInsight analysis, the Vagus Nerve Stimulators Market is witnessing a surge primarily due to the rising prevalence of neurological diseases, the increasing popularity of VNS therapy as an alternative or even conjunctive treatment in cases where drug resistance develops, growing research in studying the effects of VNS on other indications, technological advancements leading to the development of new products such as non-invasive Vagus Nerve Stimulation devices, and others.

Request for sample report @ Vagus Nerve Stimulators Market Insights [https://www.delveinsight.com/sample-request/cancer-biomarkers-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Key Takeaways from the Global Vagus Nerve Stimulators Market

* According to DelveInsight analysis, North America is anticipated to dominate the global Vagus Nerve Stimulators market during the forecast period.
* The leading Vagus Nerve Stimulators companies such as LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH, and others are currently dominating the Vagus Nerve Stimulators market.
* In February 2023, LivaNova PLC, a market-leading medical technology and innovation company, launched SenTiva DUO, an implantable pulse generator (IPG) with a dual-pin header to provide VNS Therapy for the treatment of drug-resistant epilepsy.
* In December 2022, electroCore, Inc., a commercial stage bioelectronic company, announced the launch of a new wellness product offering called Truvaga for customers residing in the U.S.
* In August 2021, the FDA approved the MicroTransponder Vivistim Paired VNS System, a one-of-its-kind, drug rehabilitation system with the intention to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke.
* In March 2020, LivaNova received the CE Mark approval for their Vagus Nerve Stimulation VNS Therapy Registered System, Symmetry Trademark for difficult-to-treat depression.

For more insights about the Vagus Nerve Stimulators market; download the snapshot of the key highlights entailed in the Vagus Nerve Stimulators Market Report [https://www.delveinsight.com/sample-request/cancer-biomarkers-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Vagus Nerve Stimulators

A Vagus Nerve Stimulator is a pacemaker-like device that comes with an implantable programmable generator that is implanted in the chest wall and delivers electrical impulses to the vagus nerve in the neck thereby stimulating the vagus nerve and providing relief to patients.

The FDA has approved an implantable vagus nerve stimulator to treat epilepsy and depression. In addition, in Europe, new non-invasive vagus nerve stimulation devices that do not require surgical implantation to treat epilepsy, depression, and pain have been approved.

Vagus Nerve Stimulators Market Insights

North America is estimated to account for the largest share in the Vagus Nerve Stimulation (VNS) devices market among all the regions. The key driving factors of the North America Vagus Nerve Stimulators market are the high prevalence of epilepsy, depression in the region, increasing disposable income, rising investments, and big collaborative expansions by key players in the region. Moreover, the conducive regulatory environment in the region is expected to establish the dominance of the North American Vagus Nerve Stimulation (VNS) devices market in the overall global landscape.

Furthermore, advanced product launches and commercialization agreements among the key VNS companies are further expected to fuel the Vagus Nerve Stimulators market. For instance, in August 2021, the FDA approved drug-free rehabilitation system intended to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke-a stroke caused by a blockage of blood flow to the brain with long-lasting symptoms the first-of-its-kind Vagus Nerve Stimulation device the MicroTransponder Vivistim Paired VNS System. Thus, the interplay of all the aforementioned factors is likely to fuel the Vagus Nerve Stimulators market growth in the United States during the forecast period.

For further information about the scenario of the Vagus Nerve Stimulators market in other geographies, visit Vagus Nerve Stimulators Market [https://www.delveinsight.com/sample-request/cancer-biomarkers-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Vagus Nerve Stimulators Market Dynamics

The Vagus Nerve Stimulators market is experiencing an increase in product demand for a variety of reasons, with one of the key reasons being the rising prevalence of neurological disorders. Moreover, with more positive results being reported concerning the VNS therapy, more research is being conducted on different disease areas, which may further expand the application of Vagus Nerve Stimulation devices in the coming years. For instance, several studies are ongoing in studying the effects of VNS on tinnitus, irritable bowel syndrome, and chronic pain, among other indications. This further presents an opportunity for making significant headway in the Vagus Nerve Stimulators market in the near future.

However, procedure-related complications and the high cost of these devices may be confining factors for the Vagus Nerve Stimulators market growth.

Get a sneak peek at the Vagus Nerve Stimulators market dynamics @ Vagus Nerve Stimulators Market Dynamics Analysis [https://www.delveinsight.com/sample-request/cancer-biomarkers-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Scope of the Vagus Nerve Stimulators Market Report

* Coverage: Global
* Study Period: 2022-2030
* VNS Market Segmentation By Product Type- Invasive Vagus Nerve Stimulation Devices and Non-Invasive Vagus Nerve Stimulation Devices
* VNS Market Segmentation by Application- Migraine, Epilepsy, Depression, and Others
* VNS Market Segmentation By End-User - Hospitals, Specialty Clinics, and Others
* VNS Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
* Key Vagus Nerve Stimulators Companies - LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH, and others.
* Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
* DelveInsight Analysis: The Vagus Nerve Stimulators market is expected to grow at a CAGR of 9.06% during the forecast period (2024-30).

Request to know more about Vagus Nerve Stimulators products and mechanism @ Vagus Nerve Stimulation Companies [https://www.delveinsight.com/sample-request/cancer-biomarkers-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Table of Contents

1. Vagus Nerve Stimulators Market Report Introduction

2. Vagus Nerve Stimulators Market Executive summary

3. Regulatory and Patent Analysis

4. Vagus Nerve Stimulators Market Key Factors Analysis

5. Porter's Five Forces Analysis

6. COVID-19 Impact Analysis on Vagus Nerve Stimulators Market

7. Vagus Nerve Stimulators Market Layout

8. Vagus Nerve Stimulators Global Company Share Analysis - Key 3-5 Companies

9. Vagus Nerve Stimulators Market Company and Product Profiles

10. Project Approach

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=vagus-nerve-stimulators-market-is-expected-to-witness-positive-growth-with-a-cagr-of-906-by-2030-estimates-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/aacr-annual-meeting

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.